Hydroxychloroquine sulfate is indicated for the suppressive treatment and treatment of acute attacks of malaria due to Plasmodium vivax, P. malariae, P. ovale, and susceptible strains of P. falciparum. It is also indicated for the treatment of discoid and systemic lupus erythematosus and rheumatoid arthritis. CONTRAlNDICATIONS
Hydroxychloroquine sulfate tablets, USP are indicated for the treatment of chronic discoid lupus erythematosus and systemic lupus erythematosus in adults. Rheumatoid Arthritis
PLAQUENIL (hydroxychloroquine sulfate) tablets contain 200 mg hydroxychloroquine sulfate, equivalent to 155 mg base, and are for oral administration.
The molecular w eight of hydroxych loroquine sulfate, USP is 433.95, and molecular formula is C 18H26ClN3O.H2SO4. Hydroxychloroquine sulfate tablets, USP contain hydroxychloroquine sulfate, USP 200 mg equival ent to 155 mg of base, and are for oral administration. Inactive In gredien ts: Crospovidone, lactose monohydrate and magne sium ste arate.
APO-HYDROXYQUINE (hydroxychloroquine sulfate) is indicated for the treatment of rheumatoid arthritis, and discoid and systemic lupus erythematosus, in patients who have not responded satisfactorily to drugs with less potential for serious side effects.
Hydroxychloroquine - Uses, Side Effects, and More - WebMD
2024年10月1日 · Find patient medical information for Hydroxychloroquine on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
HYDROXYCHLOROQUINE (hydroxychloroquine sulfate tablets) is indicated for: • the treatment of rheumatoid arthritis, and discoid and systemic lupus erythematosus, in adult patients who have not responded satisfactorily to drugs with less potential for serious
PLAQUENIL (hydroxychloroquine sulfate tablets) is indicated for the treatment of rheumatoid arthritis, and discoid and systemic lupus erythematosus, in patients who have not responded satisfactorily to drugs with less potential for serious side effects.
2022年5月27日 · Hydroxychloroquine Sulfate Tablets. DEFINITION. Hydroxychloroquine Sulfate Tablets contain NLT 93.0% and NMT 107.0% of the labeled amount of hydroxychloroquine sulfate (C H ClNO · HSO). IDENTIFICATION • A. I —O N B 〈 181〉 Sample solution: Nominally 20 mg/mL of hydroxychloroquine sulfate in water prepared as follows.
Alert - June 15, 2020: Based on FDA’s continued review of the scientific evidence available for hydroxychloroquine sulfate (HCQ) and chloroquine phosphate (CQ) to treat COVID-19, FDA has...